Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for Stroke

NCT02930018 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1105

Enrollment

INDUSTRY

Sponsor class

Conditions

Stroke, Acute

Interventions

DRUG: Nerinetide (NA-1), 2.6 mg/kg
DRUG: Placebo

Sponsor

NoNO Inc.

Collaborators

[object Object]